Intarcia Therapeutics intarcia.com


Public list: Unicorns - Billion Dollar Startups (235) BIO 2016 (619) Smart Money VCs (6327) Pharma Startups (4733)

Intarcia Therapeutics is a biopharmaceutical company developing therapies to ensure the best treatment outcome by optimizing patient convenience and adherence. Intarcia is addressing challenging diseases that require long-term chronic therapy by enhancing efficacy and reducing the burden therapies often place on the patient's life. Intarcia's drug development expertise and competitive edge is demonstrated by its ability to stabilize macromolecules and to deliver them in a constant and consistent...Show all

Intarcia Therapeutics is a biopharmaceutical company developing therapies to ensure the best treatment outcome by optimizing patient convenience and adherence. Intarcia is addressing challenging diseases that require long-term chronic therapy by enha...Show all

Company (Alive / Active)

Phone: 617-936-2500

Fax:

155 Seaport Boulevard
11th Floor
Boston, 02210
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Intarcia Therapeutics $1513.7M Apr 3, 2017
See all 96 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Intarcia Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 38 investors

Competitors

Company Status Description Investors

Allon Therapeutics

San Diego, California, United States
AcquiredAllon Therapeutics Inc. is a clinical-stage biotechnology company focused on developing the first drugs that impact the progression of neurodegernative diseases. Therapies available today treat only symptoms and have no effect on the course of the diseases.Login to see details

ARYX Therapeutics

Fremont, California, United States
IPO / Went publicARYx Therapeutics is a privately-held pharmaceutical research and development company focused on addressing safety concerns in well-established and commercially successful existing therapies through application of its proprietary ARYx RetroMetabolic (ARM) drug design. ARYx improves today's drugs, making proven therapies safer. ARYx currently has three products in clinical trials. For more information, please see the company's web site at www.aryx.com.Login to see details
See all 96 competitors